Last updated: August 15, 2025
Overview of Patent RU2010150345
Patent RU2010150345, granted by the Russian Federation, pertains to a pharmaceutical invention. The patent’s primary objective is to protect a specific drug formulation, method of synthesis, or therapeutic use pertinent to a particular medical condition. Since patents serve to carve out exclusive rights for innovations, understanding its scope and claims provides insight into its potential market influence and competitive landscape.
Patent Details and Basic Bibliographic Data
- Patent Number: RU2010150345
- Grant Date: (Assumption based on typical patent lifecycle management, e.g., 2010)
- Title: (Typically includes a drug name, formulation, or therapeutic method; specific title required)
- Applicant/Owner: (Name of pharmaceutical company or inventor; for example purposes, assume a major Russian pharma entity)
- Inventors: (Names of inventors, if available)
- Filing Date: (Historical data, likely prior to 2010)
- Patent Term: 20 years from filing date, subject to maintenance fees
(Note: Precise bibliographic data should be obtained from the official Russian patent database, Federal Institute of Industrial Property (FIPS).)
Scope and Claims Analysis
Scope of the Patent
The scope is primarily determined by the claims section, which defines the legal boundaries of patent protection. It is essential to analyze the claims to understand what is specifically protected.
Claims Overview:
- The patent likely claims a specific chemical entity, pharmaceutical composition, or method of synthesis.
- It may include claims directed towards therapeutic use—e.g., treatment of a specific disease.
- Dependent claims further specify particular embodiments, such as concentrations, dosages, or administration routes.
Expected Characteristics:
- Broad Claims: May cover a class of compounds or formulations, providing extensive protection.
- Narrow Claims: Could focus on a particular compound or method, limiting scope to specific embodiments.
(Note: Without access to the actual claims text, a hypothetical analysis is provided. Actual claims should be interpreted from the official patent document.)
Claims Breakdown
-
Independent Claims:
-
Likely define the core invention, such as a novel pharmaceutical compound or a unique method of synthesis.
-
May claim a specific chemical structure with certain substitutions or configurations.
-
Dependent Claims:
- Specify particular embodiments or variations—e.g., specific dosage forms, combinations, or administration regimes.
Legal Significance:
- The breadth of the independent claims determines how easily competitors can design around the patent.
- Narrow claims limit monopoly scope but are easier to defend or enforce.
- Broad claims afford extensive protection but risk invalidation if prior art undermines their novelty or inventive step.
Patent Landscape Analysis in Russia
Russian Pharmaceutical Patent Environment
Russia's patent landscape for pharmaceuticals is governed by its national laws aligned with the TRIPS agreement, with notable features:
- Patentability: Novelty, inventive step, and industrial applicability are required.
- Patent Examination: Conducted by FIPS, considering prior art, including international references.
- Patent Data Sharing: Patent data accessible through official FIPS database, with additional analysis via WIPO Patentscope or Espace.
Key Trends in Russian Drug Patents
- Incremental Innovations: Predominantly involving modifications to existing drugs—such as new formulations or delivery methods.
- Biotech and Biologics Growth: Increased filings for advanced therapeutic agents.
- Patent Litigation: Growing in importance for protecting market share post-patent grant.
Comparative Landscape
- The patent landscape in Russia often overlaps with Europe and Asia, especially regarding chemical drugs.
- Popular patent strategies include claiming various polymorphs, salts, or derivatives to extend patent life and protect competitive advantages.
Legal and Strategic Implications
- The scope of RU2010150345 suggests a potential monopoly over a particular pharmaceutical compound or formulation.
- The strength of the patent’s claims impacts generics entry—more comprehensive claims delay market competition.
- Presence of prior art or prior publications may influence the enforceability and value of the patent.
Potential Challenges and Opportunities
Challenges:
- Patent validity could be challenged if prior art undermines novelty or inventive step.
- Narrow claims may provide limited protection.
Opportunities:
- The patent can serve as a basis for licensing deals or strategic partnerships within Russia.
- It can act as a defensive tool to ward off generic competition.
Concluding Remarks
Patent RU2010150345’s scope revolves around a proprietary pharmaceutical invention, likely involving a unique chemical compound or therapeutic method. The specific claims determine its breadth and enforceability. In the context of Russia’s patent landscape, such patents are crucial for safeguarding innovative drugs from generic competition and can significantly influence local market dynamics.
Key Takeaways
- Comprehensive analysis of claims is essential to assess the patent’s scope; broad claims offer extensive market exclusivity, whereas narrow claims may limit enforcement.
- The Russian patent landscape favors incremental innovations, influencing how companies strategically file and defend patents.
- Patent protection in Russia remains aligned with international standards, offering opportunities for global pharmaceutical strategy.
- Regular monitoring of prior art and competitor filings is vital to maintain patent strength.
- Licensing and strategic collaborations can leverage the patent’s exclusivity within the Russian pharmaceutical market.
FAQs
1. What is the significance of the independent versus dependent claims in RU2010150345?
Independent claims define the core invention’s scope, establishing the broadest monopoly. Dependent claims specify particular embodiments or variations, narrowing protection but strengthening enforceability.
2. How does Russian patent law impact the protection of pharmaceutical inventions like RU2010150345?
Russian law requires novelty and inventive step; meeting these criteria grants exclusive rights. However, challenges such as prior art can limit enforceability if claims are too broad or not adequately supported.
3. Can this patent be challenged or invalidated?
Yes, through opposition procedures or court invalidation proceedings, especially if prior art or obviousness issues are identified. Regular patent maintenance is essential to sustain rights.
4. How does the patent landscape in Russia influence pharmaceutical innovation?
It encourages incremental innovations, allowing firms to build on existing drugs while securing legal protection, fostering a competitive environment. However, strict examination standards ensure only truly inventive drugs are patented.
5. What strategic considerations should companies have regarding this patent?
Companies should evaluate the patent’s scope, enforceability, and potential for licensing. They should also monitor competitor filings and prior art to defend or challenge the patent effectively.
References
[1] Official Russian Federal Institute of Industrial Property (FIPS) database.
[2] Russian Patent Law, Federal Law No. 217-FZ.
[3] WIPO Patentscope database.
